Will Eye Care even be here in a year?


anonymous

Guest
Really? Vuity shit the bed harder than a kid with the flu, both Lumigan and Alphagan lose their patents in the next year or two, there isn't anything to buy, and they certainly can't keep us in the field with just one product or even just glaucoma.

How long do we have until they just cut Eye Care?
 


Really? Vuity shit the bed harder than a kid with the flu, both Lumigan and Alphagan lose their patents in the next year or two, there isn't anything to buy, and they certainly can't keep us in the field with just one product or even just glaucoma.

How long do we have until they just cut Eye Care?


Drops will dissipate away.
 


















Allergan died May 2020. This is AbbVie. AbbVie does not care about eye care. Stay here and you are signing up to be the ugly step child.


Very spot on. Why did we even have to change? We should have stayed solo Allergan Eye Care. It didn’t have to happen, did it? We lost all our control. We are part of Abbvie but don’t even have resources for running a single commercial. We had them for Restasis for over 10 years! I’ll take Monday and reflect on the fact that Abbvie doesn’t care and yes I’m just a damn number at this point.
 


Very spot on. Why did we even have to change? We should have stayed solo Allergan Eye Care. It didn’t have to happen, did it? We lost all our control. We are part of Abbvie but don’t even have resources for running a single commercial. We had them for Restasis for over 10 years! I’ll take Monday and reflect on the fact that Abbvie doesn’t care and yes I’m just a damn number at this point.

It could never be Allergan Eye Care. This deal was about aesthetics and that's why there is a HUGE difference in the experience the aesthetics people are having with AbbVie vs the sorry lot that was integrated into the AbbVie machine. This is most apparent on the Irvine site where you literally have 2 classes of employees. And among the legacy Allergan employees, arguably Eye Care is doing the worst now that all the CNS Forest expertise was shown the door.

Now here's the fun part - the truly dirty secret. Consistent with the AbbVie message board and the spot on comments regarding the stupidity of AbbVie management, the neurotoxin was aligned to aesthetics from an R&D perspective. The problem is the aesthetics people are filler and implant experts eg device not drugs but they are posing as drug developers since they won the integration lottery and believe they earned their luck. Kind of like everyone at AbbVie thinks they are the best at whatever and do not recognize the luck of having a cash cow like Humira.

Last I checked drug development is complex and very different that a hyaluronic filler. Many of the eye care experts R&D, Commercial, etc were experts across Eye Care and Toxins. Many of the most experienced legacy Allergan people were moved to Eye Care and are actively being pushed out with their institutional knowledge of Eye Care and Toxins out the door. Bottomline, the investment AbbVie made in toxins will go down the toilet like much of their investment in the legacy AbbVie TAs. The oncology pipeline is a thing a beauty.
 


It could never be Allergan Eye Care. This deal was about aesthetics and that's why there is a HUGE difference in the experience the aesthetics people are having with AbbVie vs the sorry lot that was integrated into the AbbVie machine. This is most apparent on the Irvine site where you literally have 2 classes of employees. And among the legacy Allergan employees, arguably Eye Care is doing the worst now that all the CNS Forest expertise was shown the door.

Now here's the fun part - the truly dirty secret. Consistent with the AbbVie message board and the spot on comments regarding the stupidity of AbbVie management, the neurotoxin was aligned to aesthetics from an R&D perspective. The problem is the aesthetics people are filler and implant experts eg device not drugs but they are posing as drug developers since they won the integration lottery and believe they earned their luck. Kind of like everyone at AbbVie thinks they are the best at whatever and do not recognize the luck of having a cash cow like Humira.

Last I checked drug development is complex and very different that a hyaluronic filler. Many of the eye care experts R&D, Commercial, etc were experts across Eye Care and Toxins. Many of the most experienced legacy Allergan people were moved to Eye Care and are actively being pushed out with their institutional knowledge of Eye Care and Toxins out the door. Bottomline, the investment AbbVie made in toxins will go down the toilet like much of their investment in the legacy AbbVie TAs. The oncology pipeline is a thing a beauty.
the yes are the window to the head, it's good we celebrate this
 








Allergan was broke.

We are Abbvie for a reason.

goodbye specialty eye.
This is absurd. To have representatives speak out of turn is just infuriating. Specialty eye is not gone. Not by a long shot. If you don’t know what you are talking about don’t get on this forum spewing false info. In all my years I have never seen so many negative posts and comments. We have a bright future for those who get over this rough patch. Good day!
 


This is absurd. To have representatives speak out of turn is just infuriating. The specialty eye is not gone. Not by a long shot. If you don’t know what you are talking about don’t get on this forum spewing false info. In all my years I have never seen so many negative posts and comments. We have a bright future for those who get over this rough patch. Good day!

Rough patches can be avoided... At least this one. However, when upper management is either too stubborn or stupid to take sound advice, rough patches are inevitable. Except a prolonged rough patch here.
 


This is absurd. To have representatives speak out of turn is just infuriating. Specialty eye is not gone. Not by a long shot. If you don’t know what you are talking about don’t get on this forum spewing false info. In all my years I have never seen so many negative posts and comments. We have a bright future for those who get over this rough patch. Good day!


Hello upper management with stock options and tenure and false hope. SMH. Carry a bag why don’t ya.
 





Write your reply...